Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

London Vet Show 2023: Volition Veterinary Highlights.

Key Takeaway: Volition Veterinary launched its Nu.Q® Vet Cancer test at the London Vet Show, marking its entry into the UK and Ireland markets. Collaborating with Veterinary Pathology Group and NationWide Laboratories, the company aims to enhance early cancer diagnosis in pets. The event generated significant interest among veterinary professionals, highlighting the test's potential benefits.
Price reaction · baseline $15.78 (2023-11-30T15:50:00.000Z) · hit during market hours · 1 other VNRX headline(s) in the window, move may be shared
day 0 close · peak
-3.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Successful launch of Nu.Q® Vet Cancer test in the UK and Ireland.
  • Strong collaboration with Veterinary Pathology Group and NationWide Laboratories.
  • High interest from veterinary professionals at the London Vet Show.
  • Potential to improve early diagnosis and prolong pets' lives.

Full Press Release Details

Earlier this month, we attended London Vet Show, Europe’s largest veterinary exhibition, to launch our Nu.Q ® Vet Cancer test to the UK and Ireland markets through our two new collaborators, Veterinary Pathology Group (VPG) , and NationWide Laboratories (NVS) .
We spoke to many attendees from the veterinary field at our booth and hosted talks featuring our Research Director, Dr. Rebecca Timmons, and Dr. Sue Ettinger, aka Dr. Sue Cancer Vet, a practicing veterinary cancer specialist, international speaker, book author, and vlogger.
Watch our video for highlights of London Vet Show 2023:
Tom Butera, Chief Executive Officer of Volition Veterinary, said:
“We are launching here with VPG, which is an excellent reference laboratory here, as well as NationWide Laboratories, giving us broad coverage throughout the UK. Our tests are being ordered as we speak, and we are just delighted to finally be able to come to the UK.”
Fiona Gosling, CEO, Veterinary Pathology Group, said:
“We have had so much interest at the London Vet Show, but also so much interest since we’ve launched it. We are very excited about what we can do, hopefully bring the diagnosis earlier for the patient so that they get the result earlier and prolong the life of pets. Fundamentally, we are here for the animals.”
• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What is the Nu.Q® Vet Cancer test?

The Nu.Q® Vet Cancer test is a diagnostic tool for detecting cancer in pets.

Who are Volition Veterinary's partners in the UK?

Volition Veterinary partners with Veterinary Pathology Group and NationWide Laboratories.

What was highlighted at the London Vet Show?

The launch of the Nu.Q® Vet Cancer test and its potential to improve early diagnosis.

Who spoke at the London Vet Show?

Dr. Rebecca Timmons and Dr. Sue Ettinger presented at the event.

Last updated: Nov 30, 2023